• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
DeviceNOVACOR LVAS
Classification Nameventricular (assisst) bypass
Generic Nameventricular (assisst) bypass
Applicant
WORLD HEART, INC.
7799 pardee ln.
oakland, CA 94621
PMA NumberP980012
Date Received04/24/1998
Decision Date09/29/1998
Withdrawal Date 07/15/2011
Product Code
DSQ[ Registered Establishments with DSQ ]
Docket Number 99M-2605
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the novacor(r) lvas. This device is indicated for use as a bridge to transplantation in cardiac transplant candidates at risk of imminent death from nonreversible left ventricular failure. The lvas is indicated for use both inside and outside the hospital.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling
Supplements: S001 S003 S005 S006 
-
-